Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
CosmoFarm Delivers Record Q2 2026 Revenue of Over $15M, Representing $60+ Million Annualized Run-Rate; Adds Over 80 Pharmacies and Expands AI Automation and Facility Capacity
GlobeNewswire, Inc.
CHICAGO, June 18, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that its wholly owned subsidiary, CosmoFarm S.A....
Cosmos Health Enters the $163 Billion Global Skincare Market; Sales Already Underway in the United States
GlobeNewswire, Inc.
CHICAGO, June 17, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced its entry into the global beauty and personal care...
Cosmos Health Signs 2.86 Million-Unit Contract Manufacturing Agreement With Pharmex S.A. Across Three Dermatological Products
GlobeNewswire, Inc.
CHICAGO, June 17, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that, through its wholly owned subsidiary Cana...
Univar Solutions Expands Exclusive Beauty, Personal Care, and Pharmaceutical Ingredients Partnership with American Distilling in EMEA
GlobeNewswire, Inc.
ROTTERDAM, The Netherlands, June 17, 2026 (GLOBE NEWSWIRE) -- Univar Solutions B.V., a subsidiary of Univar Solutions LLC (“Univar Solutions" or "the Company"), a leading global solutions provider to users of specialty ingredients and chemicals,...
Ritzy Yachts Attends 2026 EMMYS in Greece to Personally Vet Yachts and Crews for Charter Season
GlobeNewswire, Inc.
Miami, Florida, June 16, 2026 (GLOBE NEWSWIRE) -- Ritzy Yachts, a luxury crewed yacht charter brokerage, attended the 2026 East Mediterranean Multihull & Yacht Charter Show (EMMYS) in Poros, Greece, to inspect fleets and meet crews ahead of the...
Cosmos Health Provides Update on United States Portfolio; Four 18 Series Products Introduced With Projected Annualized Revenue Over $22.7M and Approximately $17.0M Gross Profit
GlobeNewswire, Inc.
CHICAGO, June 15, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today provided an update on its United States market entry through the...
Cosmos Health Receives New Contract Manufacturing Orders Totaling 253,657 Units Across a Range of Medicines
GlobeNewswire, Inc.
CHICAGO, June 12, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that its wholly-owned subsidiary, Cana Laboratories...
Cosmos Health Reports Annualized Sales Exceeding $1.5M for Its C-Scrub and C-Sept Antiseptic Brands in the UK and Greece; Plans EU Expansion Targeting $7.4M in Revenue and $5.3M in Gross Profit
GlobeNewswire, Inc.
Strong sales momentum: across the UK and Greece, the brands' first two markets.
Cosmos Health Signs LOI to Acquire Doc Pharma S.A., a European GMP Pharmaceutical Manufacturer, a Transformative Step Expected to Boost Assets, Profitability, Production Capacity, and Product Portfolio
GlobeNewswire, Inc.
Doc Pharma financial profile: approximately $24 million asset base, approximately $6.7 million in average annual revenue and approximately $3.2 million in average annual gross profit.
Cosmos Health Secures Additional 180-Day Nasdaq Extension to Regain Bid Price Compliance
GlobeNewswire, Inc.
Extension granted through December 7, 2026 Reflects the Company's compliance with all other applicable Nasdaq listing requirements.
Cosmos Health Signs 3-Year Contract Manufacturing Agreement with Verisfield for 3.9 Million Units of VASCLOR GEST Progesterone Pessaries
GlobeNewswire, Inc.
CHICAGO, June 10, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that its wholly-owned subsidiary, Cana Laboratories...
Celldex Announces Multiple Upcoming Presentations from Leading Mast Cell Targeting Pipeline at the Upcoming 2026 European Academy of Allergy and Clinical Immunology Annual Congress
GlobeNewswire, Inc.
-- Flash talks on barzolvolimab clinical program in CSU and Cold Urticaria -- -- Late-breaking poster presentation on CDX-622 -- HAMPTON, N.J., June 10, 2026 (GLOBE NEWSWIRE) -- Celldex (NASDAQ:CLDX) announced today that three presentations from...
Cosmos Health CEO Issues Letter to Shareholders: Building an Innovative AI-Driven Global Healthcare Platform — Record Growth with U.S. Expansion Underway
GlobeNewswire, Inc.
Key Highlights Record revenue, continued momentum: all-time high $65.3M in FY2025; strongest-ever Q1 2026, carrying into Q2. Record operational momentum: CosmoFarm wholesale distribution and GMP-certified Cana contract manufacturing both...
Volunteers Reach Tens of Thousands Across 200 Cities Worldwide in Mental Health Outreach
GlobeNewswire, Inc.
LOS ANGELES, June 10, 2026 (GLOBE NEWSWIRE) -- More than 1,400 Dianetics volunteers mobilized across 200 cities worldwide last week, taking a unique approach to the global mental health crisis.
Cosmos Health Inaugurates State-of-the-Art Capsule Production Line with New 5-Year Contract Manufacturing Agreement with Provident Pharmaceuticals for 385,000 Units of CERTORUN
GlobeNewswire, Inc.
CHICAGO, June 09, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that its wholly-owned subsidiary, Cana Laboratories...
RetreatBoss Magazine Looks at What Modern Wellness Travel Misses: Family
EIN Presswire
The Summer 2026 issue explores family wellness travel, chosen family, grief, Bali, shared meals, retreat culture, and the spaces that help people reconnect.
Cosmos Health Completes Acquisition of Strategic Intellectual Property and Expands Nanotechnology Investment Initiatives
GlobeNewswire, Inc.
KEY HIGHLIGHTS Cana Laboratories, Cosmos Health's wholly owned subsidiary, acquires international patent application WO2025108566A1 from Cloudpharm P.C. Patent protection being pursued at national and regional levels across key international...
Organic Yogurt Market to Reach USD 22.30 Billion by 2033 as Demand for Cleaner-Label Dairy and Plant-Based Alternatives Accelerates Worldwide: Verified Market Research®
GlobeNewswire, Inc.
Lewes, Delaware, June 18, 2026 (GLOBE NEWSWIRE) -- The Global Organic Yogurt Market is witnessing sustained expansion as consumers increasingly prioritize cleaner-label food products, functional nutrition, and certified organic offerings....
Cosmos Health Continues U.S. Expansion with Launch of Oliv18, Targeting Cardiovascular and Antioxidant Categories
GlobeNewswire, Inc.
Oliv18™ expands the 18 Series with a USDA and EU organic certified, 100% solvent-free, whole olive polyphenol formulation from the Moroccan Saharan desert Hydroxytyrosol — the key active in Oliv18™ — is the highest ORAC polyphenol A single 250 mg...
Cosmos Health Achieves Pan-European Distribution for Sky Premium Life Across All 27 EU Member States Through Leading E-Commerce Platform Skroutz
GlobeNewswire, Inc.
CHICAGO, June 04, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that its proprietary brand, Sky Premium Life, is now...
Sign up for:
Greece Wellness Wire
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.